Larry Biegelsen
Stock Analyst at Wells Fargo
(3.87)
# 675
Out of 5,116 analysts
352
Total ratings
56%
Success rate
7.69%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KMTS Kestra Medical Technologies | Maintains: Overweight | $27 → $28 | $27.15 | +3.13% | 3 | Dec 12, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $114 → $139 | $122.76 | +13.23% | 8 | Dec 10, 2025 | |
| COO The Cooper Companies | Maintains: Equal-Weight | $72 → $82 | $82.62 | -0.75% | 20 | Dec 5, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $95 → $96 | $86.85 | +10.54% | 18 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Overweight | $100 → $114 | $96.52 | +18.11% | 19 | Nov 19, 2025 | |
| SYK Stryker | Maintains: Overweight | $452 → $456 | $354.22 | +28.73% | 17 | Nov 14, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $16 → $17 | $17.18 | -1.05% | 9 | Nov 14, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $103 → $95 | $87.39 | +8.71% | 12 | Nov 14, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $13 → $14 | $22.35 | -37.36% | 11 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $10.93 | -8.51% | 15 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $101 → $90 | $95.47 | -5.73% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $93 | $67.57 | +37.64% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $122 | $116.21 | +4.98% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $87 | $83.61 | +4.05% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $124 → $125 | $96.06 | +30.13% | 15 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $577.81 | +3.84% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $170 → $212 | $207.63 | +2.10% | 14 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.06 | -19.81% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $93 | $80.38 | +15.70% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $2.22 | +35.14% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $19.38 | +23.84% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $316.97 | -8.51% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $13.47 | +7.65% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $90.77 | +7.97% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $16.02 | +6.12% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $12.62 | +288.27% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $124.84 | +8.94% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $88.41 | -20.82% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $196.33 | +37.52% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $66.71 | - | 2 | Nov 2, 2017 |
Kestra Medical Technologies
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $27.15
Upside: +3.13%
Teleflex
Dec 10, 2025
Maintains: Equal-Weight
Price Target: $114 → $139
Current: $122.76
Upside: +13.23%
The Cooper Companies
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $82.62
Upside: -0.75%
Edwards Lifesciences
Dec 5, 2025
Maintains: Overweight
Price Target: $95 → $96
Current: $86.85
Upside: +10.54%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $96.52
Upside: +18.11%
Stryker
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $354.22
Upside: +28.73%
Bausch + Lomb
Nov 14, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.18
Upside: -1.05%
Merit Medical Systems
Nov 14, 2025
Maintains: Overweight
Price Target: $103 → $95
Current: $87.39
Upside: +8.71%
Tandem Diabetes Care
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $22.35
Upside: -37.36%
RxSight
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $10.93
Upside: -8.51%
Nov 4, 2025
Upgrades: Overweight
Price Target: $101 → $90
Current: $95.47
Upside: -5.73%
Oct 31, 2025
Maintains: Overweight
Price Target: $98 → $93
Current: $67.57
Upside: +37.64%
Oct 30, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $116.21
Upside: +4.98%
Oct 30, 2025
Maintains: Overweight
Price Target: $89 → $87
Current: $83.61
Upside: +4.05%
Oct 23, 2025
Maintains: Overweight
Price Target: $124 → $125
Current: $96.06
Upside: +30.13%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $577.81
Upside: +3.84%
Oct 3, 2025
Upgrades: Overweight
Price Target: $170 → $212
Current: $207.63
Upside: +2.10%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.06
Upside: -19.81%
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $80.38
Upside: +15.70%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $2.22
Upside: +35.14%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $19.38
Upside: +23.84%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $316.97
Upside: -8.51%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $13.47
Upside: +7.65%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $90.77
Upside: +7.97%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $16.02
Upside: +6.12%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $12.62
Upside: +288.27%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $124.84
Upside: +8.94%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $88.41
Upside: -20.82%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $196.33
Upside: +37.52%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $66.71
Upside: -